Clinical Trials Directory

Trials / Unknown

UnknownNCT04878679

Effect of WB-EMS on Parkinson's Disease

Effects of Combined Whole Body Electromiostimulation (WB-EMS) and Dynamic Movements on Motor and Cognitive Performance, Neurotrophic Factors and Alpha-synuclein in Parkinson's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Università degli studi di Roma Foro Italico · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

The aim is to establish adequate and suitable protocols for PD patients and to determine the WB-EMS effects on muscle strength, balance, walking, cognitive functions,neurotrophic factors and alpha-synuclein. Thirty-six PD patients, aged from 50 to 80 years, will be recruited and randomly assigned to two experimental groups (EGs and EGc) and one control group (CG), in order to perform dynamic movements with WB-EMS. EGs will undergo to 12-20 minutes of progressive supervised WB-EMS (4 sec. 85 HZ and 4 sec. rests) combined to light dynamic movements, two-time per week for 12/24 weeks. EGe will undergo to 12-20 minutes of progressive supervised WB-EMS 7 Hz) combined with cardiovascular training with rowing machine. CG will not perform any type of physical activity. Pre and post intervention assessment will be carried out on the following areas: physical assessment, neurocognitive, neurotrophic factors and alpha-synuclein assesments. A 3 months follow-up will be performed.

Conditions

Interventions

TypeNameDescription
OTHERStrenght training combined with WB-EMSBodyweight exercise training combined with WB-EMS (2 times/week) with a 85Hz electrical impulse
OTHERCardiovascular training with WB-EMSCardiovascular training , using the rowing machine, combined with WB-EMS (2 times/week) with a 7Hz electrical impulse
OTHERControl groupNo physical activity

Timeline

Start date
2021-04-15
Primary completion
2022-09-23
Completion
2023-04-30
First posted
2021-05-07
Last updated
2023-05-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04878679. Inclusion in this directory is not an endorsement.